Esophageal Diseases  >>  Triapine (3-AP)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Triapine (3-AP) / Vion, Northwestern University
NCT00077545: 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction

Completed
2
39
US
triapine, cisplatin
National Cancer Institute (NCI)
Adenocarcinoma of the Esophagus, Recurrent Esophageal Cancer, Stage IV Esophageal Cancer
03/07
 

Download Options